RVL Pharmaceuticals's total assets for Q2 2023 were $85.40M, a decrease of -23.13% from the previous quarter. RVLPQ total liabilities were $69.08M for the fiscal quarter, a -2.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.